Track market-moving stories before they get noisy

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of International Business Machines Corporation ("IBM" or the "Company") (NYSE: IBM).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether IBM and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On July 14, 2026, IBM released its financial results for the second quarter of 2026.  IBM announced a disappointing quarter that it attributed to "a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing."  IBM also disclosed that it had "faltered," and "did not adapt and move quickly enough" so that "numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall." 

On this news, IBM's stock price fell $73.16 per share, or 25.21%, to close at $217.07 per share on July 14, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

By PYMNTS  |  July 16, 2026

 | 

Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal overhaul into a commercial product line. “Virtually everything that we do, we see it basically as the operating infrastructure of the future,” Chairman and CEO Stephen Hemsley said Wednesday (July 15) on the company’s second-quarter 2026 earnings call. “It really is occurring across the spectrum of our businesses.”

The results are showing up in the numbers. AI-powered prior authorization is achieving a 96% first-pass approval rate. The company committed this quarter to eliminating 30% of prior authorization volume by year-end and nearly two-thirds of prior authorization requirements for pediatric care. Those efficiencies are flowing straight to the bottom line, with second-quarter operating earnings up 55% year over year.

Where AI Is Doing the Work At Optum Health, which delivers care directly to 20 million patients, ambient listening AI tools are available to 70% of employed clinicians and are on track to reach 90% by year end. The technology transcribes patient encounters in real time, removing the documentation burden that drives clinician burnout. Optum CEO Patrick Conway said during the call that the tool has produced a 90% reduction in cognitive burnout among clinicians who use it.

Conway also noted that AI is helping nurses summarize complex patient cases 40% faster. Enhanced care transition support has driven a 10% reduction in hospitalizations in the Western and Southern regions since late last year. Home health pilots have cut readmissions and reduced skilled nursing facility stays.

In claims processing, complex cases that once required manual review are now processed automatically and with higher accuracy. “Very complex claims that we never before thought we would be able to automate, we’re able to automate those and process those with higher accuracy,” said Tim Noel, CEO of UnitedHealthcare. Patient-facing hours expanded by nearly 200,000 in the first half of the year as AI-assisted scheduling cut wait times for specialist appointments.

Selling the Playbook to the Rest of the Industry Optum Insight is converting those internal tools into commercial products sold to health systems and payers outside UnitedHealth. About a third of Optum Insight’s technology investment this year is going toward that commercialization effort.

A digital prior authorization product launched last quarter under the Optum Real branch has processed roughly half a million prior authorizations and saved 69,000 administrative hours for external clients. Value Connect, an AI insights platform embedded directly in provider electronic health records, is showing a 17% reduction in pharmacy costs in early client deployments.

Hemsley said every internal function, including HR, finance, legal and clinical operations, is being rebuilt around AI. The efficiency gains from that work will become the product Optum Insight sells externally. About a third of Optum Insight’s investment this year is going toward commercializing internal use cases for outside clients. “This is the beginning,” Hemsley said, “but it will have compounding effects as we make these investments.”

What Else Stood Out UnitedHealth committed to processing 80% of prior authorizations in real time by end of 2027, eliminating most of the back-and-forth between health plans and providers that currently delays care and drives administrative cost on both sides. Commercial insurance cost trends are running modestly above 11%, driven partly by an arbitration process under the No Surprises Act that UnitedHealth says is being exploited. Roughly 60% of all arbitration cases are brought by just five entities, and average payouts when arbitrators side with providers now run 11 times what Medicare would pay. Medicare Advantage cost trends are coming in below original planning assumptions, driven by benefit design changes and network adjustments. Full-year Medicare margins are now expected to finish above 3%. Optum Health now reaches nearly 90% of U.S. counties and conducts approximately 2.5 million rural patient home visits annually, with plans to expand those programs across the full Optum Health footprint by year-end. Topline Results and Outlook UnitedHealth reported second-quarter adjusted earnings per share of $6.38, compared with $4.08 in the prior year. Total revenues were $112 billion, largely flat year over year. Operating earnings of $8 billion grew 55% year over year. The medical care ratio was 86.7%, including $860 million of net favorable prior period medical development, compared to 89.4% in the second quarter of 2025.

Operating cash flows were approximately $11 billion, or 1.9 times net income. The debt-to-capital ratio fell to 41.2%, down from 44.1% a year ago. The company closed its acquisition of Alegeus Technologies on July 2.

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of First Solar, Inc. (NASDAQ: FSLR) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"), of the important August 24, 2026 lead plaintiff deadline.

SO WHAT: If you purchased First Solar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) defendants had overstated First Solar's capacity to manage the impact of U.S. tariff policy on First Solar's business; (2) defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305517

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

, /PRNewswire/ -- Lemonade (NYSE: LMND) today announced it will release its second quarter 2026 financial results on Wednesday, July 29, 2026 prior to market open, and will host a conference call that same day to discuss the results.

Webcast and Conference Call details:

Date: Wednesday, July 29, 2026 Time: 8:00 am Eastern time (5:00 am Pacific time) Participant Toll-Free Dial-In Number: +1 833-461-5787 Participant Toll Dial-In Number: +1 585-542-9983 Access Code: 869 766 992 Conference call registration link Webcast registration link Following the completion of the call, a replay will also be made available at lemonade.com/investor.

In addition to the dial-in options, shareholders can participate by submitting questions prior to the earnings call. The Q&A platform will be open for question submission starting July 21, 2026 at 8:00 am ET. Shareholders will be able to submit and upvote questions until July 28, 2026 at 8:00 am ET. For any support inquiries please email [email protected].

About Lemonade

Lemonade offers renters, homeowners, car, pet, and life insurance. Powered by artificial intelligence and social impact, Lemonade's full stack insurance carriers in the US and the EU replace brokers and bureaucracy with bots and machine learning, aiming for zero paperwork and instant everything. A Certified B-Corp, Lemonade gives unused premiums to nonprofits selected by its community, during its annual Giveback. Lemonade is currently available in the United States, Germany, the Netherlands, France, and the UK, and continues to expand globally.

Follow Lemonade on X and Instagram for updates.

Cautionary Note Regarding Forward-Looking Statements

This press release and our earnings release and call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this press release are forward-looking statements, including the date and time of the earnings call.

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements expressed or implied to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to the following: our financial outlook and results, our financial metrics, including our key performance indicators, our ability to acquire new business, including growth of products in new states and Europe, the expected benefits, accuracy and growth of our predictive and generative AI models, and their effects on handling loss ratios, LAE and other metrics, our anticipated growth, profitability, our industry, business strategy, plans, goals and expectations concerning our market position, future operations, reinsurance coverage, capital efficiency ratio, and other financial and operating information, our history of losses and that we may not achieve or maintain profitability in the future; our success and ability to retain and expand our customer base; the "Lemonade" brand may not become as widely known as incumbents' brands or the brand may become tarnished; the denial of claims or our failure to accurately and timely pay claims; our ability to attain greater value from each user; availability of reinsurance at current levels and prices; our exposure to counterparty risks; our limited operating history; our ability to manage our growth effectively; our proprietary artificial intelligence algorithms may not operate properly or as expected; the intense competition in the segments of the insurance industry in which we operate; our ability to maintain our risk-based capital at the required levels; our ability to expand our product offerings; the novelty of our business model and its unpredictable efficacy and susceptibility to unintended consequences; the possibility that we could be forced to modify or eliminate our Giveback; regulatory risks, related to the operation, development, and implementation of our proprietary artificial intelligence algorithms and telematics based pricing model; legislation or legal requirements that may affect how we communicate with customers; the cyclical nature of the insurance industry; our reliance on artificial intelligence, telematics, mobile technology, and our digital platforms to collect data that we utilize in our business; our ability to obtain additional capital to the extent required to grow our business, which may not be available on terms acceptable to us or at all; our actual or perceived failure to protect customer information and other data as a result of security incidents or real or perceived errors, failures or bugs in our systems, website or app, respect customers' privacy, or comply with data privacy and security laws and regulations; periodic examinations by state insurance regulators; our ability to underwrite risks accurately and charge competitive yet profitable rates to our customers; potentially significant expenses incurred in connection with any new products before generating revenue from such products; risks associated with any costs incurred and other risks as we expand our business in the U.S. and internationally; our ability to comply with extensive insurance industry regulations; our ability to comply with insurance regulators and additional reporting requirements on insurance holding companies; our ability to predict the impacts of severe weather events and catastrophes, including the effects of climate change and global pandemics, on our business and the global economy generally; increasing scrutiny, actions, and changing expectations on environmental, social, and governance matters; our agreements with third parties as a synthetic agent may not function as expected; fluctuations of our results of operations on a quarterly and annual basis; our utilization of customer and third party data in underwriting our policies; limitations in the analytical models used to assess and predict our exposure to catastrophe losses; potential losses could be greater than our loss and loss adjustment expense reserves; the minimum capital and surplus requirements our insurance subsidiaries are required to have; assessments and other surcharges from state guaranty funds; our status and obligations as a public benefit corporation; our operations in Israel and the current political, economic, and military instability, including the evolving conflict in Israel and surrounding region.

These and other important factors described under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026, and in our other subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's beliefs as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

NEWS & INFORMATION DISCLOSURE

Investors should note we may use our website (investor.lemonade.com), blog (lemonade.com/blog), X (@Lemonade_Inc), and LinkedIn as a means of disclosing information and for complying with our disclosure obligations under Regulation FD. The information we post through these channels may be deemed material. Investors should monitor these channels in addition to reviewing our press releases, SEC filings, and public conference calls.

SOURCE Lemonade, Inc.

By PYMNTS  |  July 16, 2026

 | 

GameStop CEO Ryan Cohen said Thursday (July 16) that the company continues to pursue an acquisition of eBay, Bloomberg reported Thursday.

In an interview with Bloomberg TV, Cohen declined to say whether he planned to raise his offer for the company but said “we’re coming for eBay one way or another,” according to the report.

EBay rejected a $56 billion offer from GameStop earlier this year, the report said.

Cohen said Thursday that he aims to turn the combined company into a $1 trillion business, in part by building a digital marketplace for video game items, taking advantage of synergies between the companies’ collectibles businesses, and using GameStop locations as hubs for authenticating trading cards, per the report.

“The pro forma company is going to be investment grade,” Cohen said.

PYMNTS reported May 3 that GameStop announced that it had submitted a nonbinding proposal to acquire 100% of eBay and that following closing, Cohen would serve as CEO of the new combined company.

In a letter to eBay, GameStop said that eBay had spent $2.4 billion on sales and marketing during fiscal year 2025 and added just 1 million net active buyers. GameStop pledged to cut around $1.2 billion in sales and marketing costs as part of $2 billion in annual cost reductions within 12 months of closing.

On May 12, PYMNTS reported that eBay rebuffed GameStop’s $56 billion acquisition offer and called the proposal “neither credible nor attractive.”

EBay said in an announcement that its board had reviewed the surprise takeover bid and decided to reject it based on eBay’s “standalone prospects,” “uncertainty” on how the deal would be financed, and the impact of the bid on its long-term profitability and growth.

GameStop said in a June 26 press release that its “leadership team remains focused on advancing the proposed acquisition of eBay” and that “additional materials regarding the proposed transaction are forthcoming.”

On July 7, GameStop said in a press release that its stockholders approved an increase in the number of authorized shares of Class A common stock and that this amendment “provides the Company with the capacity to issue common stock in connection with strategic acquisitions, including its proposed acquisition of eBay, Inc.”

The full moon rises in the background over the infrastructure on D Island, the main processing hub, at the Kashagan offshore oil field in the Caspian sea in western Kazakhstan August 21, 2013.... Purchase Licensing Rights, opens new tab Read more

PERTH, July 17 (Reuters) - Oil prices inched higher on Friday after the U.S. and Iran stepped up attacks across the Gulf, with their broken truce limiting oil ​flows out of the Strait of Hormuz and with Tehran asking the Houthi ‌movement to stand ready to shut the Red Sea export route.

Brent crude futures rose $1.05, or about 1.25%, to $85.28 a barrel by 0118 GMT, and U.S. West Texas Intermediate futures rose $1.03, or 1.3%, ​to $79.98 a barrel, erasing losses from the previous session.

The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.

Both benchmark contracts have ​climbed nearly 12% this week, with Brent on track for a third ⁠consecutive weekly gain and WTI for a second weekly gain.

For the first time ​since a memorandum of understanding paused fighting last month, the United States launched two big ​waves of air strikes in a single day on Wednesday, mostly on targets near Iran's southern coast, and kept firing on Thursday.

"Oil security is still a critical issue," International Energy Agency Executive ​Director Fatih Birol said on Thursday at a Council on Foreign Relations event in Washington.

"We ​should be worried, and I am worried, if the situation does not improve in the next ‌few ⁠weeks," he said.

In a statement, U.S. Central Command said U.S. forces began "a new wave of strikes against Iran for the sixth consecutive night to further degrade Iranian military capabilities" at 2 p.m. EDT (1800 GMT) or 9:30 p.m. in Tehran.

Tehran has countered with missiles and ​drones targeted at ​U.S. military bases in ⁠neighbouring states, including a barrage at a recently expanded air base in Jordan.

Adding to oil supply concerns, Iran's leadership has told ​its Houthi allies to be prepared to close the Red ​Sea oil ⁠route if the U.S. strikes Iranian power infrastructure, three sources told Reuters.

IG analysts said technically, WTI could test the mid-$80s if it holds above key support in the mid-$70s.

Separately, Trump ⁠Media & ​Technology Group unveiled a paid-for, licensed data feed that will ​give banks and trading firms "the fastest" access to posts from influential Truth Social accounts, such as President ​Donald Trump's, whose posts often move oil markets.

Reporting by Helen Clark; Editing by Sonali Paul

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Storied railroad freight company Union Pacific (UNP +3.84%) had a fine Thursday on the stock market. Thanks in no small part to an analyst's price target increase, its shares thundered nearly 4% higher that trading session.

On the right track That morning, Bernstein SocGen prognosticator David Vernon made that change. He now believes Union Pacific stock is worth $346 per share; his previous level was $330. More importantly, he maintained his positive view on the stock by maintaining his outperform (i.e., buy) recommendation.

Image source: Getty Images.

A single analyst move doesn't necessarily push a stock higher or lower. What compounded this one is that it followed two other bullish analyst takes, both coming on Wednesday.

The first was from Nathan Martin of Benchmark, who upped his price target to $325 per share from $300, and kept his buy recommendation intact. The second was the initiation of coverage by Citizens JMP, which began covering transportation sector titles. The firm's Jeff Kauffman flagged Union Pacific as an outperform, with a relatively high price target of $350.

Today's Change

(

3.84

%) $

11.06

Current Price

$

299.42

Rolling with the recovery According to reports, Kauffman wrote that what he considers to be the early phase of an economic recovery in the U.S. will be a major catalyst for improvements in earnings for the transportation sector generally and Union Pacific specifically in the coming quarters.

While I don't believe we're in a serious slump, I'd agree that our economy is positioned for some improvement. So I'd buy this argument, which certainly supports the buy case for Union Pacific's equity.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Union Pacific. The Motley Fool has a disclosure policy.

4:15pm: Semiconductor selloff Wall Street ended lower on Thursday, with semiconductor stocks leading the decline as investors took a step back from the AI trade despite another round of solid corporate earnings.

The Nasdaq bore the brunt of the selling, falling 387 points, or 1.5%, to 25,882 as chipmakers came under heavy pressure. The S&P 500 lost 39 points, or 0.5%, to close at 7,534, while the Dow proved more resilient, slipping 106 points, or 0.2%, to 52,553.

The biggest drag came from the semiconductor sector, where the Philadelphia Semiconductor Index tumbled as investors questioned whether massive spending on AI infrastructure will continue delivering the strong returns that have fueled the industry's rally. Major names including Nvidia, Micron Technology, and Broadcom all finished sharply lower, weighing heavily on the broader market.

Investors also looked ahead to Netflix's quarterly earnings, due after the closing bell, with the streaming giant expected to offer another glimpse into consumer demand and the health of the technology sector.

3:45pm: Proactive news headlines Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) retained its Outperform rating from Noble Capital Markets, which said the company is well-positioned for multiple development and exploration catalysts in the second half of 2026. Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) maintained its Outperform rating from Noble Capital Markets after successfully converting lithium carbonate from its Angel Island project into high-purity lithium metal and battery cells. AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) agreed to be acquired by Eli Lilly in a deal worth up to approximately $3.8 billion, strengthening Lilly's neuroscience pipeline with investigational mental health therapies. American Resources Corp (NASDAQ:AREC) said its majority-owned subsidiary Electrified Materials Corporation completed a private placement that raised approximately $9.5 million in gross proceeds. Trillion Energy International Inc. (CSE:TCF, OTCQB:TRLEF, FRA:Z620) finalized plans for a 40-kilometre 2D seismic survey on its M47c,d oil block in Türkiye, with exploration work scheduled to begin in late summer 2026. Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF, FRA:0XD) reported preliminary testing from its Kavango West 1X discovery well in Namibia, successfully producing hydrocarbons to the surface and advancing testing of additional formations. Montero Mining and Exploration Ltd (TSX-V:MON, OTC:MXTRF) completed the first drill hole of its 2026 exploration program at the Elvira gold project in Chile, targeting high-priority mineralization identified through geological analysis and AI-assisted data integration. 374Water Inc (NASDAQ:SCWO, FRA:8LL) signed a memorandum of understanding with Arcadis to jointly pursue federal and commercial contracts for PFAS waste destruction using its AirSCWO technology. Medicus Pharma (NASDAQ:MDCX) received US FDA feedback and central Institutional Review Board approval for its optimized Phase 2 study of Teverelix, reducing planned enrollment while advancing development of the treatment for acute urinary retention. Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X) maintained its full-year production and cost guidance after second-quarter gold production from its Segilola mine in Nigeria kept the company on track to meet its annual targets. 2:45pm: Market movers AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) agreed to be acquired by Eli Lilly and Co (NYSE:LLY) in a deal worth up to approximately $3.8 billion, strengthening Lilly's neuroscience pipeline with investigational mental health therapies. Cintas Corporation (NASDAQ:CTAS) was upgraded to Buy by Bank of America, which raised its price target after the company's stronger-than-expected fourth-quarter results and upbeat fiscal 2027 outlook reinforced confidence in its earnings growth. Abbott Laboratories (NYSE:ABT) shares surged after the healthcare company reported second-quarter earnings that beat expectations and raised its full-year adjusted earnings guidance. GE Aerospace reported better-than-expected second-quarter earnings and revenue, although its shares declined as investors focused on high expectations and moderating order growth. UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose in after-hours trading after the health insurer delivered stronger-than-expected second-quarter earnings and increased its full-year adjusted earnings outlook. Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) reported a 77% increase in second-quarter profit and raised its capital spending forecast as strong demand for AI chips continued to drive growth. Medicus Pharma (NASDAQ:MDCX) received US FDA feedback and central Institutional Review Board approval for an optimized Phase 2 study of Teverelix, reducing the planned enrollment while advancing development of the treatment for acute urinary retention. 1:15pm: Netflix due up Netflix Inc (NASDAQ:NFLX, XETRA:NFC) (Netflix Inc (NASDAQ:NFLX, XETRA:NFC), Netflix Inc (NASDAQ:NFLX, XETRA:NFC)) reports second quarter earnings tonight, and two major brokerages are sticking with their bullish calls even as the stock has struggled this year.

Shares were little changed Thursday at $73.50, but that stability masks a rough 2026 for Netflix investors: the stock has fallen more than 20% year-to-date.

Jefferies reiterated its Buy rating and $110 price target, while Bank of America kept its own Buy rating and $125 price objective. Both firms see the pullback as a buying opportunity rather than a red flag, even as they acknowledge the market's patience is being tested.

Jefferies doesn't expect a meaningful upside surprise in second quarter or full-year revenue guidance. It's forecasting constant-currency revenue growth of 12% year-over-year for both the second and third quarters, in line with Wall Street. The firm also doesn't expect Netflix to lift its full-year revenue outlook this quarter, citing soft third-party subscription data.

Bank of America is looking for largely in-line financial results, with investors more focused on the company's second-half outlook, engagement trends, and any commentary on acquisition appetite and broader strategic priorities.

11:50am: AI stocks out of favor Investors are still favoring stocks with little direct exposure to AI, according to Chris Beauchamp, Chief Market Analyst at online trading and investing platform IG.

“Right now, not being so dependent on chip stocks is a good thing. The rotation in markets has seen money desert chip and AI stocks, and flow to areas where these are either less prominent or non-existent,” Beauchamp wrote.

“(T)he Dow and Russell 2000 continue to show greater resilience than the techy Nasdaq & S&P 500. This is all healthy market action, but is little comfort to latecomers to the tech rally, who were assuming that the euphoria for the sector would continue.”

10:55am: Retail sales rise US retail sales rose 0.2% in June from the previous month, reflecting lower gasoline prices while underlying consumer spending remained resilient.

Online retailers and auto dealers led June retail sales gains with 1.9% increases, while a sharp 5.3% drop in gasoline station sales—along with declines in clothing, grocery, and health and personal care stores—weighed on the overall results.

Bill Adams, chief US economist at Fifth Third Commercial Bank, said the softer headline growth was "actually good news," as it reflected falling gas prices rather than weakening demand.

Excluding gas stations, retail sales increased a robust 0.7% in June, while core retail sales (which exclude food services, gas stations and autos) rose 0.4%. Control group sales, which feed directly into GDP calculations, advanced 0.5%.

Adams also noted that upward revisions to April and May retail sales suggest stronger consumer spending than previously estimated, supporting expectations for an upgrade to second-quarter US GDP growth estimates.

10am: Uneven start There was another uneven start for Wall Street on Thursday with stocks searching for direction. 

The Dow Jones started 0.2% higher, before slipping to flat, while the Nasdaq dropped over 1% initially before cutting this to an 0.8% deficit. The S&P 500 has slipped 0.3%.

Healthcare stocks led the gains after upbeat earnings, with Abbott jumping 11.8% to top the S&P leaderboard and insurer UnitedHealth rising 8.8%, making it the Dow's best performer.

Technology stocks remain under pressure, with SanDisk again the biggest faller on the Nasdaq 100, down 9.4%, followed by memory peers Seagate and Western Digital, both down around 7%, then AI chipmakers including Arm, Marvell, Micron, Qualcomm, Intel, Broadcom and Nvidia also traded lower.

8.05am: Wall Street futures mixed, Lilly dips toe in psychedelics with Atai deal Wall Street looked set for a mixed open Thursday with further yo-yoing in technology stocks amidst a fresh batch of corporate earnings.

Futures pointed to the Dow Jones opening 0.2%, while the S&P 500 was called down 0.2% and the Nasdaq looked set to bear the brunt of the selling, with futures off 0.8% as semiconductor stocks see pressure.

Oil prices were little changed, with West Texas Intermediate trading just below $80 a barrel, despite further escalation in the Middle East.

Iran's military said it had launched missiles and drones at US military positions in Kuwait, Bahrain and Jordan in retaliation for an earlier US strike, while Reuters reported Tehran had instructed Yemen's Houthi movement to prepare to close the Bab el-Mandeb Strait if Washington attacks Iran's power infrastructure, raising the prospect of disruption to a second key global shipping route.

The three major US indexes all finished higher on Wednesday after softer-than-expected producer price inflation reinforced expectations that the Federal Reserve will leave interest rates unchanged later this month.

The Dow rose 150 points, or 0.3%, to 53,141.48, the S&P climbed 0.4% to 7,614.75, and the Nasdaq Composite added 0.6% to close at 25,654.64.

Weakness in Asian semiconductor names seemed to spill into US futures, as markets were unimpressed with Taiwan Semiconductor Manufacturing Co (ADR) (NYSE:TSM) beating expectations with a 77% jump in quarterly profit and upbeat guidance, citing "extremely robust" demand for AI chips. TSMC shares fell about 5% in US premarket trading though.

That follows a similar negative reaction to strong results from Dutch chip equipment maker ASML, highlighting investors' increasingly demanding expectations for AI-linked companies.

Before attention turns to Netflix Inc (NASDAQ:NFLX, XETRA:NFC) after the closing bell, there are a swathe of life science updates ahead of the open.

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) rose 6% in premarket trading after the health insurer beat second-quarter earnings expectations and raised its full-year guidance, helped by stronger operational performance despite membership headwinds.

Abbott Laboratories (NYSE:ABT) gained 3.3% as investors welcomed better-than-expected quarterly results and an upbeat outlook.

Merck & Co Inc (NYSE:MRK, XETRA:6MK) added over 1% after the FDA approved its first-in-class cholesterol pill Liprendra, while second-quarter sales edged ahead of forecasts and the drugmaker reiterated its growth outlook.

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) surged almost 34% after agreeing to a $2.8 billion takeover by Eli Lilly, with the deal including additional milestone payments that could take the total value to $3.8 billion.

Prologis Inc (NYSE:PLD) was little moved after the logistics property group beat forecasts on both funds from operations and revenue in the second quarter, signalling resilient demand for warehouse space.

From the financials, State Street Corp (NYSE:STT) climbed after the custodian bank topped expectations for earnings, revenue, net interest income and assets under management in the second quarter.

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”), of the important July 28, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (2) the foregoing was likely to, and did, have a material negative impact on Lucid’s business and financial results; (3) accordingly, the defendants had overstated the purported enhancements to Lucid’s manufacturing and delivery capabilities and overall operations; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© fizkes / Shutterstock.com

A letter arrives in late summer. The hospital system a retiree has used for 20 years, the one that houses her cardiologist and her oncologist and her primary care doctor, will no longer accept her Medicare Advantage plan as of a date printed near the bottom of page two. She had made no changes on her end. Her plan stayed in place on paper. The contract between the two of them ended, and she found out by mail.

This scenario has become common enough that it is worth understanding before the next Annual Enrollment Period. If you are on Original Medicare with a Medigap policy, this article is largely not about you. If you are on a Medicare Advantage plan, or considering one at 65, the mechanic below is the one that will most likely bite.

Why Hospitals Are Walking Away Mid-Contract Hospital systems and physician groups across the country have terminated or declined to renew Medicare Advantage contracts over the past two years, citing three recurring problems: prior-authorization friction, claim denials, and slow or low reimbursement from MA plans. In plain terms, hospitals say they treat the patient, then spend months arguing with the insurer over whether the care was necessary and how much of it will be paid.

The insurer side of the ledger explains the pressure. Elevance Health (NYSE:ELV | ELV Price Prediction), one of the largest managed care companies in the country, reported that elevated medical costs in government businesses contributed to an increased benefit expense ratio in its most recent quarter. When insurers face rising costs on MA members, they tighten authorization rules and push back harder on hospital bills. Hospitals absorb the delay, then decide the contract is not worth renewing.

The result lands in a patient’s mailbox.

What the Letter Actually Means A mid-year network termination leaves your Medicare Advantage plan in place. Your plan continues, but the hospital or physician group inside it does not. Once the termination date passes, visits to that provider are treated as out-of-network. On most HMO-style MA plans, out-of-network care is not covered at all except in emergencies. On PPO-style plans, it is covered at a higher cost share, and out-of-network spending typically does not count toward the in-network out-of-pocket maximum.

The advertised in-network cap on your plan stops protecting you the moment your hospital leaves the network.

The Protections That Actually Apply Federal continuity-of-care rules require Medicare Advantage plans to allow certain patients, typically those in active treatment for serious conditions, pregnancy, or end-stage illness, to continue seeing a departing provider at in-network cost sharing for a transitional period. The plan sets the exact terms, and the patient must request it. It is not automatic.

A Special Enrollment Period may open when a plan experiences a significant network change, which lets the member switch to another MA plan or return to Original Medicare outside the usual October-to-December window. CMS decides case by case whether an SEP applies, so the letter from the plan is the first place to check. If it grants an SEP, use it.

The Switch-Back Trap Returning to Original Medicare sounds like the clean fix. It is not that simple after the first six months of Part B enrollment. Outside that federal Medigap open enrollment window, a Medigap insurer in most states can medically underwrite, charge more, or deny coverage entirely. A handful of states, including New York, Connecticut, Massachusetts, and Maine, offer broader guaranteed-issue rights. Everywhere else, a 72-year-old with a cardiac history who wants to leave her MA plan may find Medigap effectively closed to her.

This is the cost of the original MA decision that the $0 premium never advertised. Getting in is easy. Getting out clean is not. (For retirees mapping the broader landscape of surprise Medicare costs, the Medicare’s Hidden Bills report walks through the categories worth stress-testing before enrollment.)

What To Do Now Read every plan letter the month it arrives. Network termination notices are legally required, but they look like junk mail. The effective date on page two is the only date that matters. Re-verify your provider network every Annual Enrollment Period, which runs October 15 to December 7. Do not assume last year’s network carries forward. Call the hospital’s billing office directly and ask which MA contracts they will honor for the coming plan year, not just which they accept today. If you are still inside your six-month Medigap open enrollment window, price a Medigap Plan G or Plan N against your current MA plan before that window closes. The underwriting protection you have right now expires once, and never returns in most states. With the 2026 Social Security COLA at 2.8%, most retirees have little slack in their monthly budget for an out-of-network hospital bill they did not plan for. The letter in the mailbox is the warning. The action window closes fast.

Contact [email protected] for any questions or corrections.

ToplineLettuce from a Taco Bell supplier has been identified as the possible source of the cyclosporiasis outbreak centered in the Great Lakes region, according to multiple reports, as federal and state health officials have yet to publicly announce the cause of the parasitic illness’ spread.

Iceberg lettuce in the field/Salinas Valley, California, USA.

Dana Downie/Design Pics Editorial/Universal Images Group via Getty Images

Key FactsInvestigators have identified shredded iceberg lettuce supplied by Taylor Farms to Taco Bell restaurants as the potential contamination source in a cyclosporiasis outbreak, according to two unnamed individuals familiar with the investigation who spoke to The Washington Post, with CNN also citing an unnamed source in reporting a potential link.

Taco Bell said Tuesday it was removing ingredients such as lettuce, cilantro, onion, pico de gallo and guacamole from its menus in the Detroit area.

Taylor Farms produces fruits, vegetables and pre-packaged salads, doing business with restaurants and grocery stores.

The Centers for Disease Control and Prevention has confirmed 1,645 cases across 34 states as of Tuesday, according to its latest data, which notes the agency is investigating roughly 5,100 additional possible cases.

Forbes has reached out to Taco Bell, Taylor Farms and the CDC for comment.

NEWS PEGMichigan, the epicenter of the outbreak, recorded an additional 600 cases Thursday, logging a total of 4,312 cases in the state.

TangentWhite House press secretary Karoline Leavitt said Thursday the Trump administration “has a handle on the situation,” though she acknowledged an “unusually high number of cases” and reiterated CDC guidance to wash and cook raw produce to prevent infection.

Key BackgroundThe cyclosporiasis outbreak began in May and has since resulted in 141 hospitalizations and no deaths, according to CDC data. The illness can cause watery diarrhea, loss of appetite, weight loss and low grade fever. As Michigan has reported more cases than the CDC has, the federal agency has noted it expects case counts to rise as more data is received, citing a six-week reporting lag between illness onset and case reporting. The agency has faced backlash for scaling down a federal program that previously required the 10 states participating in it to monitor cyclospora, the parasite that causes cyclosporiasis. The Trump administration said this week federal tracking of the illness did not cease because of the changes, though health care experts have warned the reduced requirements could make it more difficult for investigators to identify and track foodborne illnesses.

Further ReadingWhite House Says It Has ‘Handle’ On Cyclosporiasis Outbreak—While Urging Precautions (Forbes)

Taco Bell Investigated In Multistate Cyclosporiasis Outbreak, Report Says (Forbes)

Michigan’s Cyclosporiasis Case Count Triples In One Week—Over 4,300 Confirmed (Forbes)

LOUISVILLE, Ky.--(BUSINESS WIRE)--Yum! Brands Announces Q2 2026 Earnings and Conference Call Details.

Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.

Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.

This site is protected by reCAPTCHA.

Gold Is Testing Its 200-Day SMA—These 3 Mining Stocks Are the PlayRoyal Gold NASDAQ: RGLD highlighted recent acquisitions, stronger first-quarter results and an expanded development pipeline during a virtual non-deal roadshow hosted by Renmark Financial Communications.

Alistair Baker, senior vice president of investor relations and business development at Royal Gold, said the company’s investment thesis remains centered on “consistent cash flows from precious metals” through a royalty and streaming model, rather than direct mine ownership. He emphasized that the company is “not a mining company” and has limited direct exposure to operating cost inflation.

Get Royal Gold alerts:

The Best Way to Invest in Gold Is...Baker said Royal Gold has seen “a lot of news” over recent quarters that he believes has not yet been fully recognized by the market, adding that gold equities have been under pressure as gold “is taking a bit of a breather.”

Acquisitions Add Scale and Diversification Baker described 2025 as “a very active” and “transformational” year for Royal Gold. He cited the completion of the Sandstorm and Horizon corporate acquisitions, which he said closed in mid-October last year and added growth and diversification to the portfolio.

BHP Stock: The Under-the-Radar Growth Story in CommoditiesThe company also added gold streams at Kansanshi and Warintza. Baker said Kansanshi is a cash-flowing, “world-class copper mine in Zambia,” while Warintza is an emerging Tier 1 development project in Ecuador that Royal Gold hopes will become a world-class producing asset.

Royal Gold also reported internal portfolio developments, including a mine life extension at Mount Milligan to 2045 and potentially beyond. Baker also pointed to Barrick’s work at the Four Mile project in Nevada, which he described as “probably one of the best gold discoveries over the past several decades,” adding that Royal Gold has full exposure to it.

First-Quarter Results Set Records Baker said Royal Gold’s first quarter was the first period to include consolidated results reflecting the recent transactions. The company reported record revenue, cash flow and earnings, including $391 million in adjusted EBITDA for the quarter.

Since the middle of October, Royal Gold has repaid $800 million of debt, increased portfolio reserve life by about 25% from the prior year to 18 years, and sold more than $200 million of non-core equity positions inherited through Sandstorm, Baker said.

The company also raised its dividend at year-end for the 25th consecutive year. Baker said Royal Gold has paid a growing dividend since 2000 and has distributed more than $1 billion to shareholders over time.

Royalty Model Positioned as Lower-Risk Gold Exposure Baker said Royal Gold’s business is highly scalable, with 39 employees and low fixed costs. He said the company’s EBITDA margin in 2025 was 82%, while cash general and administrative costs were about 4% of revenue.

He contrasted the royalty and streaming model with mining operators, which face direct exposure to labor, energy and consumables inflation. Baker said Royal Gold’s costs are more stable, consisting largely of salaries, services and office rent, which should allow margins to expand when metal prices rise.

“Anything that impacts costs impacts margins,” Baker said, adding that higher energy prices could affect operator costs in upcoming quarterly results, while Royal Gold’s margins should remain comparatively consistent.

The company’s portfolio includes more than 360 assets, with about 80 producing revenue and about 30 in development. Baker said more than 250 assets remain at earlier stages, creating potential for future organic growth as projects advance.

Pipeline Includes Multiple Growth Catalysts Royal Gold pointed to several assets expected to contribute over time. Baker said Back River reached commercial production in October and should provide its first full year of contributions this year. Platreef began milling ore in the fourth quarter of last year, and Robertson at the Cortez Complex is expected to begin production in 2027.

Later in the decade, Baker said Royal Gold expects potential new production from Palomarin, Great Bear and Marimaca. After the turn of the decade, he said MARA and Four Mile could contribute in the 2030s.

He also highlighted expansion potential at existing assets, including Khoemacau, where Royal Gold expects about a 30% increase in silver deliveries starting around 2028. At Mount Milligan, Baker said the mine life extension represents “a lot of value” for the company.

Capital Allocation and Valuation in Focus Baker said Royal Gold’s capital allocation priorities remain reinvesting in the business with non-dilutive financing, maintaining a strong balance sheet and liquidity, and returning capital to shareholders.

The company recently added a $600 million accordion feature to its revolving credit facility and received board authorization for a $500 million share repurchase program. Baker said the buyback is discretionary and not tied to a formula or specific valuation levels.

In response to a question about leverage, Baker said Royal Gold could consider reaching three times net debt to EBITDA in “extreme circumstances” for a compelling acquisition, but would want to reduce leverage to two times within a reasonably quick period.

Asked about copper exposure, Baker said gold producers’ interest in copper projects is likely to continue because copper assets often have longer mine lives. He said this could create opportunities for royalty companies when copper projects contain precious metals components. Royal Gold is not targeting a specific revenue mix, he said, but remains comfortable with a portfolio that is about 90% precious metals and roughly 75% to 80% gold.

Baker said Royal Gold believes its share price is not reflecting the company’s recent performance, growth pipeline or the current gold price environment. He said the company is working to improve market understanding of its portfolio through investor outreach, an investor day and an asset handbook detailing the sources of revenue.

About Royal Gold (NASDAQ:RGLD)Royal Gold, Inc, headquartered in Denver, Colorado, is a leading precious metals streaming and royalty company. Through its business model, Royal Gold provides upfront financing to mining operators in exchange for the right to purchase a percentage of future metal production at predetermined prices. This structure allows the company to participate in production upside while minimizing exposure to the operating and capital-intensive aspects of mine ownership.

The company's portfolio encompasses interests in over 200 streams and royalties on projects across North America, South America, Europe, Africa and Australia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Royal Gold Right Now?Before you consider Royal Gold, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Royal Gold wasn't on the list.

While Royal Gold currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

In the latest close session, Paccar (PCAR - Free Report) was up +2.86% at $126.67. This change outpaced the S&P 500's 0.51% loss on the day. Meanwhile, the Dow lost 0.2%, and the Nasdaq, a tech-heavy index, lost 1.47%.

Heading into today, shares of the truck maker had gained 4.95% over the past month, outpacing the Auto-Tires-Trucks sector's loss of 3.43% and the S&P 500's gain of 0.53%.

The investment community will be paying close attention to the earnings performance of Paccar in its upcoming release. The company is slated to reveal its earnings on July 28, 2026. On that day, Paccar is projected to report earnings of $1.33 per share, which would represent a year-over-year decline of 2.92%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $7.11 billion, up 2.08% from the year-ago period.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $5.62 per share and revenue of $27.82 billion. These totals would mark changes of +12.18% and +6.05%, respectively, from last year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Paccar. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.63% higher. Paccar presently features a Zacks Rank of #3 (Hold).

Investors should also note Paccar's current valuation metrics, including its Forward P/E ratio of 21.9. For comparison, its industry has an average Forward P/E of 18.61, which means Paccar is trading at a premium to the group.

It's also important to note that PCAR currently trades at a PEG ratio of 1.14. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. PCAR's industry had an average PEG ratio of 0.99 as of yesterday's close.

The Automotive - Domestic industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 173, which puts it in the bottom 30% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that it has divested its equity stake in ICA-Fluor Daniel to its existing JV Partner, ICA for $175 million.

Key Highlights Table of Contents

Key HighlightsStrategic alliance advances SBI’s tokenized asset visionYen-backed stablecoin to power transaction infrastructureSBI constructs comprehensive blockchain finance infrastructure SBI collaborates with Ondo Finance for blockchain-based Japanese stock tokenization.

JPYSC stablecoin to facilitate settlement and collateral functions.

Ondo Finance will create tokenized instruments tied to Japanese financial markets.

SBI advances its digital securities vision through blockchain integration.

Initiative bridges Japanese capital markets with worldwide tokenized asset platforms.

Japanese financial services leader SBI has forged a strategic alliance with Ondo Finance to digitize Japanese equities through blockchain-powered tokenization. This collaboration introduces the JPYSC stablecoin as a settlement mechanism and collateral instrument for qualifying transactions. SBI plans to leverage its extensive financial network to distribute these innovative products while broadening market access to digitized Japanese securities.

Strategic alliance advances SBI’s tokenized asset vision Under this arrangement, Ondo Global Markets will assume responsibility for creating tokenized financial instruments backed by Japanese assets. SBI will then channel these products through its established financial distribution channels. Both organizations intend to promote these offerings via coordinated marketing campaigns and strategic business relationships.

We're excited to announce a partnership with SBI Group, one of Japan's leading financial institutions.

The collaboration covers tokenizing Japanese assets with distribution across the SBI ecosystem, and settlement using the JPYSC stablecoin.

Ondo CEO Ian De Bode on the… pic.twitter.com/Kp4twvDeZo

— Ondo Finance (@OndoFinance) July 16, 2026

Moreover, this collaboration establishes a bridge between Japan’s traditional financial assets and emerging global tokenized markets powered by distributed ledger technology. Neither party has revealed a specific timeline for product deployment. Details regarding initial asset selection for tokenization and the applicable regulatory structure remain undisclosed.

This initiative reinforces SBI’s comprehensive digital asset roadmap spanning multiple financial service verticals. Simultaneously, Ondo Finance obtains entry into SBI’s extensive banking network, securities brokerage operations, investment management division, and cryptocurrency ventures. This alliance establishes an additional distribution pathway for blockchain-enabled securities throughout Japan’s financial landscape.

Yen-backed stablecoin to power transaction infrastructure The partnership encompasses provisions to incorporate JPYSC into Ondo’s tokenized financial instrument ecosystem. This stablecoin, pegged to the Japanese yen, will enable settlement operations and designated collateral mechanisms. Consequently, trades involving digitized Japanese assets may utilize a cryptocurrency directly anchored to Japan’s national currency.

Both organizations also plan to explore expanded collateral use cases for JPYSC throughout their shared ecosystem. Specific product eligibility and collateral parameters have not been revealed. The firms acknowledge that additional development efforts will establish the operational guidelines.

Ondo emphasized that Japan constitutes a significant target market for tokenized financial instruments due to its mature capital market infrastructure. Concurrently, SBI characterized Ondo as a crucial long-term collaborator for scaling digital asset offerings. Both entities aim to forge stronger connections between Japan’s domestic financial markets and worldwide blockchain networks.

SBI constructs comprehensive blockchain finance infrastructure This partnership announcement follows multiple blockchain-focused ventures recently unveiled by SBI throughout the digital finance sector. Previously, SBI Global Asset Management rolled out a tokenized Japanese equity investment vehicle on Solana’s blockchain in collaboration with DigiFT. This offering delivers institutional and accredited investors blockchain-enabled exposure to a dividend-focused Japanese equity approach.

The JX token marked DigiFT’s inaugural tokenized Japanese equity fund available on its regulated marketplace. SBI positioned this product as a pioneering tokenized Japanese equity fund. This debut expanded blockchain accessibility to Japanese equity investment strategies via compliant infrastructure.

The Ondo collaboration extends these previous initiatives by incorporating tokenized financial products alongside stablecoin settlement functionality. Beyond this agreement, SBI has recently unveiled JPYSC, rolled out lending programs for the stablecoin, established a partnership with the Solana Foundation, allocated capital to Gauntlet and EDX Markets, and finalized the Bitbank acquisition. These moves demonstrate the company’s ongoing commitment to constructing a unified blockchain financial ecosystem that integrates tokenized assets, digital currencies, trading platforms, and decentralized market infrastructure.

Oliver Dale

Editor-in-Chief of Blockonomi and founder of Kooc Media, A UK-Based Online Media Company. Believer in Open-Source Software, Blockchain Technology & a Free and Fair Internet for all. His writing has been quoted by Nasdaq, Dow Jones, Investopedia, The New Yorker, Forbes, Techcrunch & More. Contact [email protected]

THE STREET: Ondo Finance partners with SBI Group to bring Japanese stocks onchain

While most of the crypto market drifted lower on July 16, $ONDO stood out. The token climbed nearly 16% over the past 24 hours to around $0.37, reaching the upper end of its daily trading range. The rally was accompanied by a sharp increase in trading activity, with ONDO recording approximately $289.6 million in 24-hour volume. That represents a surge of over 230% in volume, making it the standout mover of the session.

What is driving the move The catalyst is concrete. @OndoFinance launched the first tokenized stock representations based on DTC tokenized entitlements to DTC-held securities generated through the DTCC Tokenization Service, which leverages the same underlying DTC infrastructure that clears and settles the vast majority of US securities transactions.

These tokenized entitlements carry the same CUSIP and symbol as the underlying securities and can be delivered to DTC Participant wallets. In other words, this is not a workaround or a synthetic proxy. It is Wall Street's actual post-trade plumbing, extended onchain.

The underlying assets are Circle's publicly listed stock (CRCL) and the SPDR S&P 500 ETF Trust (SPY), represented on-chain as CRCLon and SPYon, Ondo Stocks tokens fully backed by each security. Ondo achieved this through onboarding via Alpaca Markets as a DTC participant.

Ondo joins more than a dozen leading TradFi and DeFi firms, including BlackRock, JPMorgan, Goldman Sachs, Nasdaq, and NYSE, participating in DTCC's largest tokenization initiative to date. On July 15, 2026, DTCC processed its first live production trades using tokenized versions of DTC-held assets, calling it its largest tokenization production event by breadth of assets, use cases, and participants.

What comes next for $ONDO The DTC-held securities can be converted between traditional and tokenized forms, allowing greater flexibility, access to new liquidity pools, and enhanced digital asset functionality. As the DTCC Tokenization Service continues its planned rollout later this year, Ondo expects to extend this model, making tokenized stocks accessible to on-chain investors through its global partner network of exchanges, wallets, and DeFi platforms.

Technically, the picture is mixed. The token is trading close to the top of its recent weekly range, and the latest rally pushed the price back above the widely watched 100-day EMA, though it still remains below the 200-day EMA. Volume trends and overarching price action draw question marks over the token's ability to push to $0.40 or higher. Whether $ONDO can hold the breakout, or whether this is a news-driven spike that fades, remains the key question for traders heading into the rest of the week.

Sources
Ondo Finance: Official DTCC Tokenized Stocks Announcement
BeInCrypto: Ondo Hits 1-Month High After DTCC Launch
CryptoTimes: Ondo Price Rallies 16% After DTCC Integration

Southern Co. (SO - Free Report) closed the most recent trading day at $96.07, moving +1.55% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.51%. At the same time, the Dow lost 0.2%, and the tech-heavy Nasdaq lost 1.47%.

Shares of the power company have appreciated by 2.24% over the course of the past month, outperforming the Utilities sector's gain of 0.34%, and the S&P 500's gain of 0.53%.

The investment community will be paying close attention to the earnings performance of Southern Co. in its upcoming release. The company is slated to reveal its earnings on July 30, 2026. It is anticipated that the company will report an EPS of $1, marking a 9.89% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $7.39 billion, showing a 5.94% escalation compared to the year-ago quarter.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $4.57 per share and revenue of $31.35 billion, indicating changes of +6.28% and +6.08%, respectively, compared to the previous year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Southern Co. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Southern Co. presently features a Zacks Rank of #2 (Buy).

With respect to valuation, Southern Co. is currently being traded at a Forward P/E ratio of 20.68. For comparison, its industry has an average Forward P/E of 18.14, which means Southern Co. is trading at a premium to the group.

Meanwhile, SO's PEG ratio is currently 2.86. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Utility - Electric Power industry held an average PEG ratio of 2.69.

The Utility - Electric Power industry is part of the Utilities sector. With its current Zacks Industry Rank of 158, this industry ranks in the bottom 36% of all industries, numbering over 250.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

In the latest trading session, Emcor Group (EME - Free Report) closed at $750.04, marking a -2.56% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for the day. On the other hand, the Dow registered a loss of 0.2%, and the technology-centric Nasdaq decreased by 1.47%.

The stock of construction and maintenance company has fallen by 6.98% in the past month, lagging the Construction sector's loss of 4.14% and the S&P 500's gain of 0.53%.

The investment community will be closely monitoring the performance of Emcor Group in its forthcoming earnings report. The company's earnings per share (EPS) are projected to be $7.23, reflecting a 7.59% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $4.73 billion, indicating a 9.88% growth compared to the corresponding quarter of the prior year.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $29.37 per share and a revenue of $19.02 billion, indicating changes of +13.53% and +11.97%, respectively, from the former year.

Investors should also take note of any recent adjustments to analyst estimates for Emcor Group. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Currently, Emcor Group is carrying a Zacks Rank of #1 (Strong Buy).

In terms of valuation, Emcor Group is currently trading at a Forward P/E ratio of 26.21. This represents no noticeable deviation compared to its industry average Forward P/E of 26.21.

The Building Products - Heavy Construction industry is part of the Construction sector. With its current Zacks Industry Rank of 40, this industry ranks in the top 17% of all industries, numbering over 250.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  

The investigation concerns whether HCA and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On July 14, 2026, HCA issued a press release reporting its preliminary financial and operating results for the second quarter of 2026.  Among other items, HCA sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the Company's payer mix, which impacted revenue by approximately $400 million in the quarter. 

On this news, HCA's stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between January 28, 2025 and January 26, 2026, inclusive (the "Class Period"), of the important July 17, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Commvault securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Commvault's competitive positioning was materially weaker than defendants had represented to investors; (2) due to the undisclosed increase in competition, Commvault was forced to make significant concessions on price and contract duration for its software licenses; (3) as these concessions became unsustainable, Software as a Service ("SaaS") became a larger portion of Commvault's sales mix; (4) in turn, the increasing mix of SaaS sales, which carry shorter term durations and lower average selling prices ("ASPs"), negatively impacted Commvault's margin and Net New ARR ("NNARR"); and (5) as a result, defendants' positive statements about Commvault's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305507

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FirstSun Capital Bancorp ("FirstSun" or the "Company") (NASDAQ: FSUN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether FirstSun and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

            On July 9, 2026, FirstSun disclosed that it "expect[s] charge-offs to average loans to be in the high 50s range in basis points" and projected a $40 million to $41 million provision for credit losses and $42 million to $43 million in charge-offs, including a $22 million charge-off tied to a suspected-fraud loan. 

On this news, FirstSun's stock price fell $2.85 per share, or 7.5%, to close at $35.08 per share on July 10, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

Energy Transfer LP (ET - Free Report) closed at $20.20 in the latest trading session, marking a +1.46% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 0.51% for the day. Elsewhere, the Dow lost 0.2%, while the tech-heavy Nasdaq lost 1.47%.

Shares of the energy-related services provider witnessed a gain of 6.19% over the previous month, beating the performance of the Oils-Energy sector with its gain of 0.92%, and the S&P 500's gain of 0.53%.

Investors will be eagerly watching for the performance of Energy Transfer LP in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 4, 2026. In that report, analysts expect Energy Transfer LP to post earnings of $0.37 per share. This would mark year-over-year growth of 15.63%. Simultaneously, our latest consensus estimate expects the revenue to be $30.75 billion, showing a 59.78% escalation compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates are projecting earnings of $1.43 per share and revenue of $121.19 billion, which would represent changes of +18.18% and +41.69%, respectively, from the prior year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Energy Transfer LP. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Energy Transfer LP currently has a Zacks Rank of #1 (Strong Buy).

Valuation is also important, so investors should note that Energy Transfer LP has a Forward P/E ratio of 13.97 right now. This valuation marks a discount compared to its industry average Forward P/E of 14.38.

One should further note that ET currently holds a PEG ratio of 1.15. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Oil and Gas - Production Pipeline - MLB stocks are, on average, holding a PEG ratio of 1.32 based on yesterday's closing prices.

The Oil and Gas - Production Pipeline - MLB industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 43, which puts it in the top 18% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.